Template:Carbenicillin Indanyl Sodium: Difference between revisions

Latest revision as of 04:14, 2 January 2014

Carbenicillin indanyl sodium
GEOCILLIN^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

@@ Line 19: / Line 19: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Carbenicillin indanyl sodium overdosage|Overdosage]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Carbenicillin indanyl sodium clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Carbenicillin indanyl sodium dosage and administration|Dosage and Administration]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Carbenicillin indanyl sodium how supplied|How Supplied]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Carbenicillin indanyl sodium labels and packages|Labels and Packages]]
 |-
 |}